Print Page  |  Close Window

SEC Filings

10-Q
TERRAFORM GLOBAL, INC. filed this Form 10-Q on 11/08/2017
Entire Document
 

TERRAFORM GLOBAL, INC. AND SUBSIDIARIES
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)

Nine Months Ended September 30,
 
2017
 
2016
Cash flows from operating activities:
 
 
 
Net loss
$
(56,409
)
 
$
(18,422
)
Adjustments to reconcile net loss to net cash used in operating activities:
 
 
 
Amortization of deferred financing costs
1,284

 
7,824

Depreciation, amortization and accretion
52,545

 
40,971

Stock-based compensation expense
2,568

 
2,617

Change in fair value of interest rate swaps
2,949

 
5,854

Loss on disposal of property
967

 

Loss (gain) on extinguishment of debt
6,731

 
(5,730
)
Unrealized gains on foreign currency, net
(39,278
)
 
(22,549
)
Deferred tax expense (benefit)
530

 
(1,118
)
Other non-cash items
(2,674
)
 

Changes in assets and liabilities:
 
 
 
Accounts receivable
(1,701
)
 
110

Prepaid expenses and other current assets
7,613

 
3,254

Accounts payable, accrued expenses, and other current liabilities
(50,927
)
 
(35,414
)
Due to/from affiliates, net
(2,137
)
 
(5,593
)
Restricted cash from insurance proceeds
(50,000
)
 

Shareholder litigation accrual
83,000

 

Net cash used in operating activities
(44,939
)
 
(28,196
)
Cash flows from investing activities:
 
 
 
Capital expenditures
(2,801
)
 
(66,384
)
Change in restricted cash
8,336

 
63,144

Cash paid for acquisitions, net of cash acquired

 
(32,128
)
Cash acquired upon FERSA consolidation

 
8,022

Returns from BioTherm escrow and deposits
5,317

 
5,507

Net cash provided by (used in) investing activities
10,852

 
(21,839
)
Cash flows from financing activities:


 
 
Repayment of Revolver

 
(135,000
)
Repayments of Senior Notes

 
(35,441
)
Repayments of system debt financing
(9,462
)
 
(33,102
)
Net SunEdison investment

 
50,223

Dividends paid

 
(30,674
)
Net cash used in financing activities
(9,462
)
 
(183,994
)
Net decrease in cash and cash equivalents
(43,549
)
 
(234,029
)
Effect of exchange rate changes on cash and cash equivalents
(5,709
)
 
2,309

Cash and cash equivalents at beginning of period
680,893

 
922,318

Cash and cash equivalents at end of period
$
631,635

 
$
690,598

See accompanying notes to unaudited condensed consolidated financial statements.

9